This topic contains a solution. Click here to go to the answer

Author Question: A patent A) always gives rise to a monopoly. B) may not provide a barrier to entry. C) allows ... (Read 46 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
A patent
 
  A) always gives rise to a monopoly.
  B) may not provide a barrier to entry.
  C) allows the patent owner to capture all of the consumer surplus.
  D) increases total welfare.

Question 2

Fixed costs
 
  A) are always sunk.
  B) are avoidable.
  C) are sometimes sunk.
  D) sunk in the short run, but not in the long run.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ally

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

C




JGIBBSON

  • Member
  • Posts: 538
Reply 2 on: Jul 1, 2018
Great answer, keep it coming :)


jordangronback

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Excellent

 

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library